AI investment accelerates across pharmaceuticals, automotive and financial services as companies shift from experimentation ...
IDNA surged 13.5% on catalysts and heavy volume. See valuation vs XBI, NAV exposures, and M&A tailwinds shaping returns—read ...
Opportunities center on oral therapies for chronic, age-related and autoimmune diseases, AI-enabled discovery, preclinical de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results